| Abstract: Spinal cord injury (SCI) is a debilitating condition within the neural system which is
clinically manifested by sensory-motor dysfunction, leading, in some cases, to neural paralysis for
the rest of the patient’s life. In the current study, mesenchymal stem cells (MSCs) were isolated from
the human amniotic fluid, in order to study their juxtacrine and paracrine activities. Flow cytometry
analysis was performed to identify the MSCs. A conditioned medium (CM) was collected to measure
the level of BDNF, IL-1β, and IL-6 proteins using the ELISA assay. Following the SCI induction,
MSCs and CM were injected into the lesion site, and also CM was infused intraperitoneally in the
different groups. Two weeks after SCI induction, the spinal cord samples were examined to evaluate
the expression of the doublecortin (DCX) and glial fibrillary acid protein (GFAP) markers using
immunofluorescence staining. The MSCs’ phenotype was confirmed upon the expression and unexpression of the related CD markers. Our results show that MSCs increased the expression level of
the DCX and decreased the level of the GFAP relative to the injury group (p < 0.001). Additionally, the
CM promoted the DCX expression rate (p < 0.001) and decreased the GFAP expression rate (p < 0.01) as
compared with the injury group. Noteworthily, the restorative potential of the MSCs was higher than
that of the CM (p < 0.01). Large-scale meta-analysis of transcriptomic data highlighted PAK5, ST8SIA3,
and NRXN1 as positively coexpressed genes with DCX. These genes are involved in neuroactive
ligand–receptor interaction. Overall, our data revealed that both therapeutic interventions could
promote the regeneration and restoration of the damaged neural tissue by increasing the rate of
neuroblasts and decreasing the astrocytes. |